Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Freeman

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Dementia (London, England)|September 1, 2021
Active inclusion of people living with dementia in planning for dementia care and services in low- and middle-income countriesErica Breuer, Emily Freeman, Suvarna Alladi, et al.
Frontiers in Veterinary Science|July 1, 2022
A Cross-Sectional, Population-Based, Seroepidemiological Study of Rift Valley Fever in Cameroonian Cattle PopulationsBarend Mark Bronsvoort, Robert Francis Kelly, Emily Freeman, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabIJailall Ramnauth, Mathew D Surman, Peter B Sampson, et al.
JCI Insight|March 17, 2026
Safety of a tetravalent live dengue virus vaccine in children responding to one serotype onlyLaura J White, Lindsay D Hein, Maria Abad Fernandez, et al.
Dementia (London, England)|July 1, 2021
Beyond the project: Building a strategic theory of change to address dementia care, treatment and support gaps across seven middle-income countriesErica Breuer, Adelina Comas-Herrera, Emily Freeman, et al.
Molecular Neurodegeneration|December 20, 2012
Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 miceKathryn Rogers, Kevin M Felsenstein, Lori Hrdlicka, et al.
Brain : a Journal of Neurology|February 19, 2025
Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscleSivasankar Malaichamy, Romane Idoux, Kiran Polavarapu, et al.
Journal of Medicinal Chemistry|March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitorsJohn Wityak, Kevin F McGee, Michael P Conlon, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Dementia (London, England)|September 1, 2021
Active inclusion of people living with dementia in planning for dementia care and services in low- and middle-income countriesErica Breuer, Emily Freeman, Suvarna Alladi, et al.
Frontiers in Veterinary Science|July 1, 2022
A Cross-Sectional, Population-Based, Seroepidemiological Study of Rift Valley Fever in Cameroonian Cattle PopulationsBarend Mark Bronsvoort, Robert Francis Kelly, Emily Freeman, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 2009
2,3,4,5-Tetrahydro-1H-pyrido[2,3-b and e][1,4]diazepines as inhibitors of the bacterial enoyl ACP reductase, FabIJailall Ramnauth, Mathew D Surman, Peter B Sampson, et al.
JCI Insight|March 17, 2026
Safety of a tetravalent live dengue virus vaccine in children responding to one serotype onlyLaura J White, Lindsay D Hein, Maria Abad Fernandez, et al.
Dementia (London, England)|July 1, 2021
Beyond the project: Building a strategic theory of change to address dementia care, treatment and support gaps across seven middle-income countriesErica Breuer, Adelina Comas-Herrera, Emily Freeman, et al.
Molecular Neurodegeneration|December 20, 2012
Modulation of γ-secretase by EVP-0015962 reduces amyloid deposition and behavioral deficits in Tg2576 miceKathryn Rogers, Kevin M Felsenstein, Lori Hrdlicka, et al.
Brain : a Journal of Neurology|February 19, 2025
Dominant rhabdomyolysis linked to a recurrent ATP2A2 variant reducing SERCA2 function in muscleSivasankar Malaichamy, Romane Idoux, Kiran Polavarapu, et al.
Journal of Medicinal Chemistry|March 12, 2015
Lead optimization toward proof-of-concept tools for Huntington's disease within a 4-(1H-pyrazol-4-yl)pyrimidine class of pan-JNK inhibitorsJohn Wityak, Kevin F McGee, Michael P Conlon, et al.
Pageof 5